{"product_id":"quickvue-influenza-sars-test-qui20518","title":"QuickVue Influenza\/SARS-CoV 2 Test (25\/bx)","description":"\u003cul\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eRapid\u003c\/strong\u003e Detection of Influenza A, Influenza B \u0026amp; SARS-CoV-2\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eProvides\u003c\/strong\u003e Results in Approximately 10 Minutes\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eUses\u003c\/strong\u003e Direct Anterior Nasal Swab Specimens\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eIncludes\u003c\/strong\u003e 25 Complete Tests per Kit\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eDesigned\u003c\/strong\u003e for Professional In Vitro Diagnostic Use .\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003cp\u003eThe \u003cstrong\u003eQuidel QuickVue Influenza\/SARS-CoV 2 Test\u003c\/strong\u003e is a rapid lateral flow immunoassay intended for the qualitative detection of Influenza A, Influenza B, and SARS-CoV-2 antigens from direct anterior nasal swab specimens collected from individuals with signs and symptoms of respiratory infection. Delivering results in approximately 10 minutes, the test provides healthcare professionals with a convenient point-of-care solution for rapid respiratory virus detection.\u003c\/p\u003e\n\n\u003ch4 style=\"text-align: center;\"\u003e✔ MULTIPLEX RESPIRATORY TESTING | ✔ RAPID 10-MINUTE RESULTS | ✔ SIMPLE POINT-OF-CARE WORKFLOW\u003c\/h4\u003e\n\n\u003ch4\u003eFAST \u0026amp; ACCURATE RESPIRATORY DETECTION\u003c\/h4\u003e\n\n\u003cul style=\"list-style-type: square;\"\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eQUALITATIVE DETECTION:\u003c\/strong\u003e Detects Influenza A antigen, Influenza B antigen, and SARS-CoV-2 nucleocapsid antigen from a single direct anterior nasal swab specimen, providing separate qualitative results for each target.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eRAPID RESULTS:\u003c\/strong\u003e Produces test results in approximately 10 minutes, supporting timely clinical evaluation and patient management.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eLATERAL FLOW IMMUNOASSAY:\u003c\/strong\u003e Utilizes lateral flow immunoassay technology for the qualitative detection of Influenza A antigen, Influenza B antigen, and SARS-CoV-2 nucleocapsid antigen.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003ch4\u003eSTREAMLINED POINT-OF-CARE TESTING\u003c\/h4\u003e\n\n\u003cul style=\"list-style-type: square;\"\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eSINGLE-SPECIMEN TESTING:\u003c\/strong\u003e Uses one direct anterior nasal swab specimen to evaluate three common respiratory viruses, simplifying specimen collection and testing.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003e25-TEST KIT:\u003c\/strong\u003e Each kit contains materials required to perform 25 tests, making it suitable for physician offices, urgent care centers, clinics, and clinical laboratories.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eROOM TEMPERATURE STORAGE:\u003c\/strong\u003e Test components are stored at room temperature according to the manufacturer's storage recommendations, simplifying inventory management.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003eThe Quidel QuickVue Influenza\/SARS-CoV 2 Test provides healthcare professionals with a rapid and convenient solution for the qualitative detection of Influenza A, Influenza B, and SARS-CoV-2, supporting timely diagnosis and appropriate clinical decision-making during respiratory illness seasons.\u003c\/p\u003e\n\n\u003cp\u003e\u003cb\u003e**FDA Disclaimer:\u003c\/b\u003e This combination test is not FDA cleared or approved, but only authorized under an Emergency Use Authorization for use by authorized laboratories. It is authorized for the rapid detection of proteins from SARS-CoV-2, Influenza A and B, and not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for the detection and\/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.\u003c\/p\u003e\n\n\u003cp\u003e\u003cimg src=\"https:\/\/tigermedical.com\/cdn\/shop\/files\/global_warning.png?v=1701160433\" width=\"17\" height=\"14\" alt=\"Warning\"\u003e \u003cstrong\u003eWARNING\u003c\/strong\u003e: This product can expose you to chemicals known to the State of California to cause cancer. For more information, go to \u003ca href=\"https:\/\/www.p65warnings.ca.gov\/\"\u003ewww.P65Warnings.ca.gov\u003c\/a\u003e.\u003cbr\u003e\u003c\/p\u003e","brand":"NDC","offers":[{"title":"Default Title","offer_id":55429376966947,"sku":"QUI20518","price":232.73,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0728\/6754\/5379\/files\/QUI20518_5e8c56ca-6e0e-4daf-b172-be18bc41366c.jpg?v=1785936980","url":"https:\/\/tigermedical.com\/products\/quickvue-influenza-sars-test-qui20518","provider":"Tiger Medical","version":"1.0","type":"link"}